1 completed. 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Completed 1 |
Follow GSK3352589: new trials by email Literature Review of GSK3352589 trials Research Report on GSK3352589
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Phase 1, First Time in Human (FTIH) Study to Evaluate GSK3352589, a REarranged During Transfection (RET) Growth Factor Receptor Tyrosine Kinase Inhibitor, in Healthy Volunteers GSK3352589, Matching Placebo - Irritable Bowel Syndrome | Phase 1 | Completed | GlaxoSmithKline | 68 | 2017-05-17 | 2019-08-09 |
Irritable Bowel Syndrome (1) · Multiple Endocrine Neoplasia Type 2a (1)
GlaxoSmithKline (1)
Australia (1)